Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 2  |  Page : 350-355

CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic


1 Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Interventional Therapy, Peking University Cancer Hospital & Institute, Beijing, China
3 Department of Thoracic Surgery, Shaanxi Provincial Tumor Hospital, Xi'an, China
4 Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
5 Department of Minimal-Invasive Intervention, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
6 Department of Minimally Invasive Interventional Center, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China
7 Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
8 Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
9 Department of Center of Minimally Invasive Therapies for Tumors, Beijing Hospital, National Center of Gerontology, Beijing, China
10 Department of Interventional Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
11 Department of Interventional Therapy, Jiangsu Cancer Hospital, Nanjing, China
12 Department of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
13 Department of Interventional Oncology, Renji Hospital, School of Medicine, Jiaotong University, Shanghai, China
14 Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
15 Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Tongji University, Cancer Center, Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment, Tongji University School of Medicine, Shanghai, China
16 Department of Ultrasound, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
17 Department of General Surgery, Guangdong Provincial Peoplefs Hospital, Guangdong Academy of Medical Sciences, Guangdong, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China
18 Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China
19 Department of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
20 Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Correspondence Address:
Weijun Fan
651 Dongfeng East Road, Guangzhou, Guangdong 510060
China
Xin Ye
16766 Jingshi Road, Jinan, Shandong 250014
China
Zhiqiang Meng
270 Dong'An Road, Shanghai 200032
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jcrt.JCRT_480_20

Rights and Permissions

The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and their critical morbidity and case fatality rates are high. The ablation expert committee of the Chinese Society of Clinical Oncology compiled corresponding expert recommendations. These recommendations summarize the preventive measures and management of tumor ablation treatment in medical institutions, including outpatient clinics, oncology wards, ablation operation room, and postablation follow-ups in accordance with the guidelines and protocols imposed by the National Health Commission of the People's Republic of China and the experience in management and prevention according to various hospitals. This consensus aims to reduce and prevent the spread of SARS-CoV-2 and its cross-infection between cancer patients in hospitals and provide regulatory advice and guidelines for medical personnel.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed465    
    Printed7    
    Emailed0    
    PDF Downloaded8    
    Comments [Add]    

Recommend this journal